Thanks for the warm welcome. I don't know what you are talking about in particular but the market can sometimes take a while to come to terms with a drug's outlook.
I am not sure if this could also be a factor but the melanoma trial looks like slipping into 2009 as evidenced by updated information on clinicaltrials dot gov. This comes soon after the admission that the liver trial has already slipped a couple of months.
Draw your own conclusions. Things haven't been going well lately.
PGL Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
